12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Daiichi Sankyo, Kissei Pharmaceutical sales and marketing update

Daiichi launched silodosin to treat dysuria associated with benign prostatic hyperplasia (BPH) in China. Daiichi has rights...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >